These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34321342)

  • 1. Maximising returns: combining newborn screening with gene therapy for spinal muscular atrophy.
    Gillingwater TH
    J Neurol Neurosurg Psychiatry; 2021 Dec; 92(12):1252. PubMed ID: 34321342
    [No Abstract]   [Full Text] [Related]  

  • 2. Willingness to Pay for a Newborn Screening Test for Spinal Muscular Atrophy.
    Lin PJ; Yeh WS; Neumann PJ
    Pediatr Neurol; 2017 Jan; 66():69-75. PubMed ID: 27769729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating neonatal spinal muscular atrophy: A 21st century success story?
    Tizzano EF
    Early Hum Dev; 2019 Nov; 138():104851. PubMed ID: 31604576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for spinal muscular atrophy: an impetus for newborn screening.
    EBioMedicine; 2021 Jul; 69():103507. PubMed ID: 34315607
    [No Abstract]   [Full Text] [Related]  

  • 5. Spinal Muscular Atrophy.
    Nicolau S; Waldrop MA; Connolly AM; Mendell JR
    Semin Pediatr Neurol; 2021 Apr; 37():100878. PubMed ID: 33892848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ontario Newborn Screening for Spinal Muscular Atrophy: The First Year.
    Kernohan KD; McMillan HJ; Yeh E; Lacaria M; Kowalski M; Campbell C; Dowling JJ; Gonorazky H; Marcadier J; Tarnopolsky MA; Vajsar J; Mackenzie A; Chakraborty P
    Can J Neurol Sci; 2022 Nov; 49(6):821-823. PubMed ID: 34620260
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic Testing for Patients with Spinal Muscular Atrophy.
    Brandsema JF; Gross BN; Matesanz SE
    Clin Lab Med; 2020 Sep; 40(3):357-367. PubMed ID: 32718505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correspondence on: "Discrepancy in Spinal Muscular Atrophy Incidence findings in newborn screening programs: the influence of carrier screening?" by Kay et al.
    Dangouloff T; Boemer F; Caberg JH; Servais L
    Genet Med; 2020 Nov; 22(11):1913-1914. PubMed ID: 32601389
    [No Abstract]   [Full Text] [Related]  

  • 9. Gene therapy rescues newborns with spinal muscular atrophy.
    Sheridan C
    Nat Biotechnol; 2018 Aug; 36(8):669-670. PubMed ID: 30080825
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of neonatal screening for spinal muscular atrophy in Hungary in 2023].
    Mikos B; Molnár MJ; Szatmári I; Monostori P; Bereczki C; Szabó AJ; Szabó L; Csősz K; Muzsik B; Velkey GJ
    Orv Hetil; 2024 Jul; 165(29):1122-1129. PubMed ID: 39033493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal Muscular Atrophy in the Treatment Era.
    Waldrop MA; Elsheikh BH
    Neurol Clin; 2020 Aug; 38(3):505-518. PubMed ID: 32703464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal Muscular Atrophy Treatments, Newborn Screening, and the Creation of a Neurogenetics Urgency.
    Butterfield RJ
    Semin Pediatr Neurol; 2021 Jul; 38():100899. PubMed ID: 34183144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parental Experiences with Newborn Screening and Gene Replacement Therapy for Spinal Muscular Atrophy.
    Meyer AP; Connolly AM; Vannatta K; Hacker N; Hatfield A; Decipeda A; Parker P; Willoughby A; Waldrop MA
    J Neuromuscul Dis; 2024; 11(1):129-142. PubMed ID: 38160362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal muscular atrophy: newborn and carrier screening.
    Prior TW
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):23-36, Table of Contents. PubMed ID: 20494255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness of newborn screening for spinal muscular atrophy.
    Landfeldt E
    Dev Med Child Neurol; 2023 Jan; 65(1):8-9. PubMed ID: 35698880
    [No Abstract]   [Full Text] [Related]  

  • 16. [Expert consensus on newborn screening for spinal muscular atrophy (2023 edition)].
    ;
    Zhonghua Yi Xue Za Zhi; 2023 Jul; 103(27):2075-2081. PubMed ID: 37455125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for spinal muscular atrophy.
    Sampaio H; Wilcken B; Farrar M
    Med J Aust; 2018 Aug; 209(4):147-148. PubMed ID: 30107765
    [No Abstract]   [Full Text] [Related]  

  • 18. Newborn genetic screening for spinal muscular atrophy in the UK: The views of the general population.
    Boardman FK; Sadler C; Young PJ
    Mol Genet Genomic Med; 2018 Jan; 6(1):99-108. PubMed ID: 29169204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The implementation of newborn screening for spinal muscular atrophy: the Australian experience.
    Kariyawasam DST; Russell JS; Wiley V; Alexander IE; Farrar MA
    Genet Med; 2020 Mar; 22(3):557-565. PubMed ID: 31607747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal Muscular Atrophy in the Age of Gene Therapy.
    Williams L
    AACN Adv Crit Care; 2020 Mar; 31(1):86-91. PubMed ID: 32168519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.